Our management’s extensive industry experience can accelerate your small molecule R&D and GMP program
Dr. Kiplinger has 25 years of experience in pharmaceutical and related industries, working extensively in the discovery and optimization of small molecule human and veterinary therapeutics. From 2001 through 2007, Dr. Kiplinger consulted with a variety of discovery technology companies on the optimization of chemistry discovery process. Previously, he founded the Gilson Center for Integrated Discovery Technology (CIDT) as a partnership development center responsible for high-speed chemistry and analysis products. From 1988 to 1998 at Pfizer, Dr. Kiplinger supported discovery chemistry activities by developing new applications for mass spectrometry and chromatography, in particular Open Access HPLC/MS and mass spectrometry-directed preparative chromatography.
Dr. Berger brings over 20 years of experience working in analytical contract research and instrumentation companies. Prior to joining Averica Discovery, Dr. Berger served as Project Manager at PCI Synthesis, a contract manufacturing organization (CMO), where she managed million dollar projects developing drug substances. Previously, she served as Vice President and Co-Founder of Pion, Inc., an instrumentation company and CRO, where she oversaw instrumentation sales, the CRO laboratory, and project management. In addition to her responsibilities, Dr. Berger was a key contributor to the development of Pion’s instruments and intellectual property. She also established new markets for the company, expanding their service offerings. Dr. Berger earned her Ph.D. in Chemistry from Penn State University.
Natasha Demberg is a Pharmaceutical Executive with 20+ years expertise in the development and application of Quality Management Systems throughout product life-cycle. She is skilled in leadership and management and has lead international multi-functional groups to address challenging global regulatory compliance issues. She has both hands-on expertise and a strategic view of all aspects of the pharmaceutical manufacturing process.
Natasha is presently the Vice President of Pharmaceutical Solutions at Neopharm Labs, a full service GMP analytical testing laboratory serving the Life Science industry where she is responsible for Business Development, and Customer Experience.
She is known for her dynamic leadership style and her ability to think strategically. She brings with her the tremendous mix of both technical expertise and regulatory knowledge.
Natasha’s career has included a wide range of successful leadership positions in Quality Organisations of several large companies in the pharmaceutical field. Initially as a chemist at Plantex Teva and Abbott Laboratory and later as Senior GMP Compliance Associate at Merck Frosst Canada, responsible for Quality aspect of Clinical manufacturing, and Head of Quality at Valeant Canada and Confab Laboratory responsible of entire Quality Operations.